Summary

Animal Biotechnology Market Growth & Trends

The global animal biotechnology market size is anticipated to reach USD 49.03 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.89% from 2025 to 2030. The major growth factors are government initiatives and campaigns, innovations and recent advances in animal health biotechnology, growing initiatives to educate regarding animal genetic testing and rising incidence of zoonotic diseases. For instance, in January 2021, the governments of Canada and Ontario are providing up to $4 million through the Canadian Agricultural Partnership to offer farmers improved access to veterinary services when and where they require it.

Due to a rise in the prevalence of COVID-19 across the world, many nations stipulated that only emergency or urgent procedures are certainly necessary for veterinary healthcare. Delays in routine care such as vaccination have led to certain serious health and welfare problems. Moreover, an excess of work after the lifting of COVID-19 restrictions has created further delays in the delivery of such services. Veterinary visits and diagnostic testing were significantly reduced in March, April, and May 2020 but started improving from the third quarter of 2020 with a high growth rate.

Major players observed growth during the pandemic despite the restriction and supply chain disruption. Consolidated revenues of Neogen Corporation were USD 418.2 million in fiscal 2020, an upsurge of 1.0% compared to 2019. Moreover, in June 2022, India's first COVID-19 vaccine Anocovax for animals launched. Besides Anocovac, the Agriculture Minister of India unveiled the 'CAN-CoV-2 ELISA kit' -- specific nucleocapsid protein-based indirect ELISA kit -- for antibody detection against SARS-CoV-2 in canines. Thus, such developments promote overall market growth.

Other attributes contributing to the industry growth comprise improved demand for the usage of animals in agriculture, growing awareness of animal health and welfare, meat, and animal-based products, expanding role of animals in the development of pharmaceuticals for humans, growing pet adoption, and increasing R&D investments from market players. In August 2021, INDICAL BIOSCIENCE GmbH acquired the Check-Points, Dutch R&D-focused corporation.

The industry is highly competitive as major players are focusing on product innovation, new product developments, distribution agreements, and expansion strategies to improve their market penetration. In October 2021, Embark Veterinary, Inc. released its DNA test for purebred dogs. The kit offers purebred owners exclusive, actionable health information to assist in pinpoint diagnostic, treatment plans, and monitoring that can easily be shared with a veterinarian.

Animal Biotechnology Market Report Highlights

• The vaccine product type segment was the largest revenue-generating segment in 2024. Vaccination is an effective way to lower the disease burden in animals, and it plays an important role in preventive healthcare and disease control. In December 2021, Indian Immunologicals Ltd. introduced Goat Pox Vaccine

• The preventive care of animals application segment accounted for the largest revenue share in 2024 due to the growing adoption of companion animals. An international survey by HABRI and Zoetis indicates a direct relationship between the human-animal bond and consistent veterinary care. Thus, such a human-animal bond advances to better preventive care

• The companion animal type segment is likely to grow lucratively during the forecast period owing to an increase in demand for efficient animal care and the pet-human bond owing to the associated health benefits

• In the companion animal type segment, dogs held the largest revenue share in 2024. Dogs are prone to many of the same cancers that affect humans. As per the National Cancer Institute, nearly 6 million new cancer diagnoses are made in dogs every year

• In the other, end-use segment, veterinary research institutes, and universities are expected to grow at a lucrative rate over the forecast period owing to growing R&D funding to develop advanced diagnostic tools and therapeutically advanced vaccines and medicines

• North America accounted for the largest revenue share in 2024 owing to high animal awareness levels, the presence of well-established market players, and improved healthcare infrastructure. In October 2021, Zoetis Inc. expanded its manufacturing and development facility in Tullamore, Ireland

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Animal Biotechnology Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising R&D initiatives
3.2.1.2. Rising Prevalence of Different Diseases in Animals
3.2.1.3. Increasing Regulatory Control
3.2.1.4. Support Initiatives by Industry Participants
3.2.2. Market Restraint Analysis
3.2.2.1. Technology limitations in under-developed regions
3.2.2.2. Limited Resources & Funding
3.2.2.3. Ethical Concerns
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Animal Biotechnology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
3.3.5. Product Pricing Analysis
3.3.6. COVID-19 Impact Analysis
Chapter 4. Animal Biotechnology Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Animal Biotechnology Market Product Movement Analysis
4.3. Animal Biotechnology Market Size & Trend Analysis, By Product, 2018 - 2030 (USD Million)
4.3.1. Diagnostics
4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.2. Biologics
4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3. Drugs
4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.4. Reproductive And Genetic
4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.5. Nutrition
4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Animal Biotechnology Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Animal Biotechnology Market Application Movement Analysis
5.3. Animal Biotechnology Market Size & Trend Analysis, By Application, 2018 - 2030 (USD Million)
5.3.1. Diagnosis of Animal Diseases
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Treatment of Animal Diseases
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Preventive Care of Animals
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Product Research & Development
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.5. Other Applications
5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Animal Biotechnology Market: Animal Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Animal Biotechnology Market Animal Movement Analysis
6.3. Animal Biotechnology Market Size & Trend Analysis, By Animal, 2018 - 2030 (USD Million)
6.3.1. Livestock
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.2. Poultry
6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.3. Swine
6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.4. Cattle
6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.5. Sheep & Goats
6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.6. Fish
6.3.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Companion
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2.2. Dogs
6.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2.3. Cats
6.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2.4. Horses
6.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2.5. Other Companion
6.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Animal Biotechnology Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Animal Biotechnology Market End Use Movement Analysis
7.3. Animal Biotechnology Market Size & Trend Analysis, By End Use, 2018 - 2030 (USD Million)
7.3.1. Laboratories
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Point-of-care testing/In-house testing
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Veterinary Hospitals & Clinics
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Other end use
Chapter 8. Animal Biotechnology Market: Country Estimates & Trend Analysis, by product, application, animal, & end use
8.1. Regional Dashboard
8.2. Animal Biotechnology Market Share, By Region, 2023 & 2030 USD Million
8.3. Regional Outlook
8.4. North America
8.4.1. North America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competition Insights
8.4.2.3. U.S. Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competition Insights
8.4.3.3. Canada Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competition Insights
8.4.4.3. Mexico Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competition Insights
8.5.2.3. UK Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competition Insights
8.5.3.3. Germany Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competition Insights
8.5.4.3. France Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competition Insights
8.5.5.3. Italy Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competition Insights
8.5.6.3. Spain Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Competition Insights
8.5.7.3. Denmark Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Competition Insights
8.5.8.3. Sweden Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competition Insights
8.5.9.3. Norway Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competition Insights
8.6.2.3. Japan Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competition Insights
8.6.3.3. China Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competition Insights
8.6.4.3. India Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competition Insights
8.6.5.3. Australia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competition Insights
8.6.6.3. South Korea Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Competition Insights
8.6.7.3. Thailand Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competition Insights
8.7.2.3. Brazil Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competition Insights
8.7.3.3. Argentina Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competition Insights
8.8.2.3. South Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competition Insights
8.8.3.3. Saudi Arabia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competition Insights
8.8.4.3. UAE Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competition Insights
8.8.5.3. Kuwait Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2023 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product Benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Boehringer Ingelheim
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product Benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Merck & Co. Inc.
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product Benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Virbac
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product Benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Elanco
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product Benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Idexx Laboratories
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product Benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Dechra Pharmaceuticals
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product Benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Heska Corporation
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product Benchmarking
9.7.8.4. Strategic initiatives
9.7.9. Indian Immunologicals Ltd.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product Benchmarking
9.7.9.4. Strategic initiatives
9.7.10. Hester Biosciences Pvt. Ltd.
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product Benchmarking
9.7.10.4. Strategic initiatives
9.7.11. Biogénesis Bagó
9.7.11.1. Participant’s overview
9.7.11.2. Financial performance
9.7.11.3. Product Benchmarking
9.7.11.4. Strategic initiatives
9.8. List of Other Market Players
Chapter 10. Key Takeaways